| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cue Biopharma, Inc. | Director | Stock Option (right to buy) | 24,400 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Director | 06 Jan 2026, 16:00 |
| CUE | Cue Biopharma, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Director | 03 Jan 2025, 16:00 |
| CUE | Cue Biopharma, Inc. | 02 Jan 2024 | 1 | $0 | 4 | Director | 04 Jan 2024, 16:01 |
| CUE | Cue Biopharma, Inc. | 11 Apr 2023 | 0 | $0 | 3 | Director | 13 Apr 2023, 16:43 |
| CUE | Cue Biopharma, Inc. | 11 Apr 2023 | 1 | $0 | 4 | Director | 13 Apr 2023, 16:42 |